“Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-Year Results from the POETYK PSO Program”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s365. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/2672.